| Higher expression of NEK2 (n = 57) | Lower expression of NEK2 (n = 46) | P |
---|---|---|---|
Sex, Male (%) | 49 (86.0) | 36 (78.3) | 0.446 |
Age (mean (SD)) | 66.61 (9.47) | 64.61 (7.40) | 0.243 |
Size (mean (SD)) | 4.70 (1.79) | 4.83 (1.77) | 0.717 |
Location (%) | Â | Â | 0.779 |
 Middle | 46 (80.7) | 39 (84.8) |  |
 Others | 10 (19.3) | 8 (15.2) |  |
Morphology (%) | Â | Â | 0.111 |
 Plaque | 11 (19.3) | 5 (10.9) |  |
 Fungoid | 12 (21.1) | 14 (30.4) |  |
 Ulcerative | 0 (0.0) | 3 (6.5) |  |
 Medullary | 34 (59.6) | 24 (52.2) |  |
Grade (%) | Â | Â | 0.001 |
 G1 | 2 (3.5) | 13 (28.3) |  |
 G2 | 40 (70.2) | 28 (60.9) |  |
 G3 | 15 (26.3) | 5 (10.8) |  |
Invasion depth (%) | Â | Â | 0.557 |
 Submucosal | 1 (1.8) | 2 (4.3) |  |
 Muscular | 14 (24.6) | 14 (30.4) |  |
 Serosa | 42 (73.7) | 30 (65.2) |  |
Lymph node metastasis | Â | Â | 0.029 |
 Yes | 34 (59.6) | 17 (37.0) |  |
 No | 23 (40.4) | 29 (63.0) |  |
T stage (%) | Â | Â | 0.462 |
 T1 | 1 (1.8) | 2 (4.3) |  |
 T2 | 13 (22.8) | 13 (28.3) |  |
 T3 | 41 (71.9) | 31 (67.4) |  |
 T4 | 2 (3.5) | 0 (0.0) |  |
N stage (%) | Â | Â | 0.065 |
 N0 | 23 (40.4) | 29 (63.0) |  |
 N1 | 20 (35.1) | 11 (23.9) |  |
 N2 | 10 (17.5) | 6 (13.0) |  |
 N3 | 4 (7.0) | 0 (0.0) |  |
Metastasis | 0 | 0 | Â |
AJCC* stage (%) | Â | Â | 0.001 |
 I | 1 (1.8) | 5 (10.9) |  |
 II | 22 (38.6) | 24 (52.2) |  |
 III | 27 (47.4) | 17 (37.0) |  |
 IV | 7 (12.3) | 0 (0.0) |  |